AstraZeneca Nexium NDA Includes "On-Demand" Dosing

 
• By The Pink Sheet

AstraZeneca's NDA for the Prilosec follow-on product Nexium includes an indication for "on demand" maintenance treatment for gastroesophageal reflux disease.

More from Archive

More from Pink Sheet